This Company’s Push For a COVID-19 Treatment has Its Stock on the Mend
Japanese pharmaceutical company Takeda Pharmaceutical (TAK) is introduce an antibody treatment for COVID-19 patients sometime this year. The treatment is being developed by harvesting antibodies from people that have already recovered from the virus. The company’s efforts to develop a treatment is also finding support from the U.S. government following the order from President Trump to the FDA to fast-track COVID-19 drugs and vaccines.
“We have to remove every barrier or a lot of barriers that were unnecessary, and they’ve done that to get the rapid deployment of safe, effective treatments,” Trump said at a White House briefing.
While TAK was late the vaccine game, they are working quickly to produce some form of treatment. As other companies that have been working on a vaccine have generally benefited, TAK broke a key level of support just above $16 on increasing volume. Since March 16, the price has stabilized and the was able to produce some high-volume advances that couldn’t sustain itself as it tested $14.
- Claim Your Free Options Income Blueprint Today
This simple trading blueprint shows how anyone could make extra income every week at home. See how some have made $1000’s extra a week using the strategies in the free report.
I urgently suggest you download it today.
Today, the price was able to clear that level on average volume. It looks like the share price may finally be reflecting the potential of companies working to develop solutions to a growing novel coronavirus problem
The near-term potential for TAK is to retest the prior resistance at $16 and then move to the top end of its prior channel at $18.
For option traders, the 15 May 20 $15 call option could be bought for around $1. If the price of the stock reaches $18 by expiration, the option will be worth $3 for a 200% gain. If the stock reaches $16 in the next couple weeks, consider selling the $15 strike and buying the $16, removing most of your original cost basis. This process is called a “roll.”